Efficacy of Zidovudine and Human Immunodeficiency Virus (HIV) Hyperimmune Immunoglobulin for Reducing Perinatal HIV Transmission from HIV‐Infected Women with Advanced Disease: Results of Pediatric AIDS Clinical Trials Group Protocol 185E. Richard Stiehm, Hunter Hammill, James Korelitz et al.|The Journal of Infectious Diseases|1999Cited by 149
Pharmacokinetics of Saquinavir plus Low-Dose Ritonavir in Human Immunodeficiency Virus-Infected Pregnant WomenEdward P. Acosta, Lynne Mofenson, Arlene Bardeguez et al.|Antimicrobial Agents and Chemotherapy|2004Cited by 89
Risk factors for preterm birth, low birth weight, and intrauterine growth retardation in infants born to HIV-infected pregnant women receiving zidovudineJohn S. Lambert, Mary Glenn Fowler, D. Heather Watts et al.|AIDS|2000Cited by 80
Safety and Pharmacokinetics of Hyperimmune Anti-Human Immunodeficiency Virus (HIV) Immunoglobulin Administered to HIV-Infected Pregnant Women and Their NewbornsJohn S. Lambert, Alice Stek, Lynne Mofenson et al.|The Journal of Infectious Diseases|1997Cited by 63
Pharmacokinetics and Safety of Nelfinavir When Used in Combination with Zidovudine and Lamivudine in HIV-Infected Pregnant Women: Pediatric AIDS Clinical Trials Group (PACTG) Protocol 353Yvonne J. Bryson, Mark Mirochnick, Alice Stek et al.|HIV Clinical Trials|2008Cited by 48